Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment

被引:42
作者
Belloni, Daniela [1 ]
Heltai, Silvia [1 ]
Ponzoni, Maurilio [2 ,3 ]
Villa, Antonello [4 ]
Vergani, Barbara [4 ]
Pecciarini, Lorenza [2 ]
Marcatti, Magda [5 ]
Girlanda, Stefania [5 ]
Tonon, Giovanni [6 ]
Ciceri, Fabio [3 ,5 ]
Caligaris-Cappio, Federico [1 ,3 ,7 ]
Ferrarini, Marina [1 ]
Ferrero, Elisabetta [1 ]
机构
[1] IRCCS San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Pathol Unit, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
[4] Univ Milano Bicocca, Consorzio MIA, Milan, Italy
[5] IRCCS San Raffaele Sci Inst, Hematol, Milan, Italy
[6] Ist Sci San Raffaele, Div Expt Oncol, Funct Genom Canc Unit, Milan, Italy
[7] AIRC, Milan, Italy
关键词
CANCER DEVELOPMENT; CELLS; RESISTANCE; TISSUE; BORTEZOMIB; AKT; PROLIFERATION; MECHANISMS; PROMOTES; THERAPY;
D O I
10.3324/haematol.2017.167486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple myeloma develops primarily inside the bone marrow microenvironment, that confers pro-survival signals and drug resistance. 3D cultures that reproduce multiple myeloma-bone marrow interactions are needed to fully investigate multiple myeloma pathogenesis and response to drugs. To this purpose, we exploited the 3D Rotary Cell Culture System bioreactor technology for myeloma-bone marrow co-cultures in gelatin scaffolds. The model was validated with myeloma cell lines that, as assessed by histochemical and electron-microscopic analyses, engaged contacts with stromal cells and endothelial cells. Consistently, pro-survival signaling and also cell adhesion-mediated drug resistance were significantly higher in 3D than in 2D parallel co-cultures. The contribution of the VLA-4/VCAM1 pathway to resistance to bortezomib was modeled by the use of VCAM1 transfectants. Soluble factor-mediated drug resistance could be also demonstrated in both 2D and 3D co-cultures. The system was then successfully applied to co-cultures of primary myeloma cells-primary myeloma bone marrow stromal cells from patients and endothelial cells, allowing the development of functional myeloma-stroma interactions and MM cell long-term survival. Significantly, genomic analysis performed in a high-risk myeloma patient demonstrated that culture in bioreactor paralleled the expansion of the clone that ultimately dominated in vivo. Finally, the impact of bortezomib on myeloma cells and on specialized functions of the microenvironment could be evaluated. Our findings indicate that 3D dynamic culture of reconstructed human multiple myeloma microenvironments in bioreactor may represent a useful platform for drug testing and for studying tumor-stroma molecular interactions.
引用
收藏
页码:707 / 716
页数:10
相关论文
共 44 条
  • [31] Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma
    Noborio-Hatano, K.
    Kikuchi, J.
    Takatoku, M.
    Shimizu, R.
    Wada, T.
    Ueda, M.
    Nobuyoshi, M.
    Oh, I.
    Sato, K.
    Suzuki, T.
    Ozaki, K.
    Mori, M.
    Nagai, T.
    Muroi, K.
    Kano, Y.
    Furukawa, Y.
    Ozawa, K.
    [J]. ONCOGENE, 2009, 28 (02) : 231 - 242
  • [32] The third dimension bridges the gap between cell culture and live tissue
    Pampaloni, Francesco
    Reynaud, Emmanuel G.
    Stelzer, Ernst H. K.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (10) : 839 - 845
  • [33] Bone marrow microenvironment and the identification of new targets for myeloma therapy
    Podar, K.
    Chauhan, D.
    Anderson, K. C.
    [J]. LEUKEMIA, 2009, 23 (01) : 10 - 24
  • [34] The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
    Podar, Klaus
    Zimmerhackl, Alexander
    Fulciniti, Mariateresa
    Tonon, Giovanni
    Hainz, Ursula
    Tai, Yu-Tzu
    Vallet, Sonia
    Halama, Niels
    Jaeger, Dirk
    Olson, Dian L.
    Sattler, Martin
    Chauhan, Dharminder
    Anderson, Kenneth C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (04) : 438 - 448
  • [35] Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast
    Reagan, Michaela R.
    Liaw, Lucy
    Rosen, Clifford J.
    Ghobrial, Irene M.
    [J]. BONE, 2015, 75 : 161 - 169
  • [36] Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model
    Reagan, Michaela R.
    Mishima, Yuji
    Glavey, Siobhan V.
    Zhang, Yong
    Manier, Salomon
    Lu, Zhi Ning
    Memarzadeh, Masoumeh
    Zhang, Yu
    Sacco, Antonio
    Aljawai, Yosra
    Shi, Jiantao
    Tai, Yu-Tzu
    Ready, John E.
    Kaplan, David L.
    Roccaro, Aldo M.
    Ghobrial, Irene M.
    [J]. BLOOD, 2014, 124 (22) : 3250 - 3259
  • [37] Modeling tissue-specific signaling and organ function in three dimensions
    Schmeichel, KL
    Bissell, MJ
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (12) : 2377 - 2388
  • [38] Tumor stroma and regulation of cancer development
    Tlsty, Thea D.
    Coussens, Lisa M.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) : 119 - 150
  • [39] Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Ogawa, Naoki
    Sakamoto, Kotaro
    Shimaoka, Hirotaka
    Fujita, Arisa
    Itoh, Tatsuki
    Imano, Motohiro
    Ishizaka, Toshihiko
    Satou, Takao
    Nishida, Shozo
    [J]. LEUKEMIA RESEARCH, 2015, 39 (04) : 445 - 452
  • [40] Modeling tissue morphogenesis and cancer in 3D
    Yamada, Kenneth M.
    Cukierman, Edna
    [J]. CELL, 2007, 130 (04) : 601 - 610